Table 1 presents the characteristics of the study participants. Patients with HT were more likely (p < 10-4) to have lower serum levels of luteinizing hormone (LH), dehydroepiandrosterone (DHEAS), androstenedione, testosterone, 17-OH-PRG, and LH/follicle-stimulating hormone (FSH) ratio and higher levels of PRG than patients with combined PCOS and HT. The gene discussed is BRD2; the disease is hematocrit.